ARTICLE | Company News
Ligand receives approval in Europe
October 18, 2000 7:00 AM UTC
The European Commission granted marketing approval for LGND's Panretin 0.1 percent alitretinoin topical gel to treat cutaneous lesions in patients with AIDS-related Kaposi's sarcoma. Panretin gel was ...